Profile data is unavailable for this security.
About the company
Jiangsu Cowin Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of molecular detection products. The Company is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The Company's products are exported to the United States, Peru, Germany and other countries and regions.
- Revenue in CNY (TTM)123.20m
- Net income in CNY-117.37m
- Incorporated2010
- Employees657.00
- LocationJiangsu Cowin Biotech Co LtdNo. 18 Zelan RoadMedical High tech ZoneTAIZHOU 225311ChinaCHN
- Phone+86 52 386200880
- Fax+86 52 386200880
- Websitehttps://www.cwbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Shengda Bio-pharm Co Ltd | 742.96m | -53.74m | 2.10bn | 1.03k | -- | 1.68 | -- | 2.82 | -0.3325 | -0.3325 | 4.27 | 7.31 | 0.4409 | 2.33 | 6.08 | 719,919.20 | -3.10 | 3.39 | -3.71 | 4.42 | 15.03 | 28.58 | -7.02 | 7.57 | 1.41 | -- | 0.2268 | 39.98 | -1.44 | 8.10 | -271.70 | -- | 11.22 | -6.89 |
Jiangsu gdk Biotechnology Co Ltd | 33.39m | -128.83m | 2.18bn | 451.00 | -- | 1.62 | -- | 65.42 | -1.04 | -1.04 | 0.2686 | 10.95 | 0.0193 | 0.4185 | 0.1529 | 74,034.57 | -7.45 | 3.30 | -8.73 | 4.84 | 51.14 | 75.56 | -385.83 | 12.58 | 3.20 | -- | 0.048 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
Jiangsu Cowin Biotech Co Ltd | 123.20m | -117.37m | 2.18bn | 657.00 | -- | 1.34 | -- | 17.73 | -1.12 | -1.12 | 1.21 | 14.49 | 0.0664 | 1.33 | 1.23 | 187,520.90 | -6.63 | -- | -6.94 | -- | 58.15 | -- | -99.82 | -- | 14.37 | -- | 0.0184 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
Hanshang Group Co Ltd | 1.36bn | 49.62m | 2.23bn | 2.38k | 44.35 | 1.30 | -- | 1.64 | 0.1707 | 0.1707 | 4.65 | 5.84 | 0.3705 | 2.75 | 8.35 | 573,421.20 | 1.16 | 2.00 | 1.92 | 3.89 | 58.35 | 57.24 | 3.13 | 4.89 | 0.3366 | 2.15 | 0.3198 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
Shanghai Shen Lian Biomedical Corp | 281.44m | 25.86m | 2.28bn | 365.00 | 88.30 | 1.52 | -- | 8.11 | 0.063 | 0.063 | 0.6854 | 3.66 | 0.1731 | 0.7474 | 0.9025 | 771,056.40 | 1.54 | 6.85 | 1.65 | 7.54 | 70.64 | 79.21 | 8.92 | 29.63 | 6.58 | -- | 0.0008 | 30.78 | -8.32 | 1.70 | -44.56 | -9.14 | -2.08 | -- |
Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 384.44m | 26.95m | 2.33bn | 787.00 | 86.32 | 3.20 | -- | 6.07 | 0.0708 | 0.0708 | 1.01 | 1.91 | 0.367 | 1.38 | 1.79 | 488,492.20 | 2.57 | -4.59 | 3.60 | -6.24 | 48.38 | 29.54 | 7.01 | -18.40 | 1.44 | -- | 0.0021 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
Data as of May 17 2024. Currency figures normalised to Jiangsu Cowin Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 4.05m | 15.84% |
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 2.00m | 7.83% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 311.68k | 1.22% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 306.20k | 1.20% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 275.10k | 1.08% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 217.27k | 0.85% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 200.00k | 0.78% |
Essence Fund Co., Ltd.as of 31 Dec 2023 | 191.39k | 0.75% |
Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 152.24k | 0.60% |
Wanjia Asset Management Co., Ltd.as of 30 Jun 2023 | 96.65k | 0.38% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.